Two weeks of walking and breathing before lung surgery may cut pain and hospital stay
NCT ID NCT07401056
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a two-week program of walking and breathing exercises before surgery for non-small cell lung cancer can help reduce pain, speed up recovery, shorten hospital stays, and improve quality of life. About 62 adults scheduled for surgery will be split into two groups: one doing the exercises and one receiving standard care. The goal is to see if preparing the body before surgery leads to better outcomes afterward.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 62 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria 1. Age ≥ 18 years. 2. Ownership of a smartphone capable of tracking daily walking time. 3. Diagnosis of primary non-small cell lung cancer. 4. ASA (American Society of Anesthesiologists) classification I, II, or III. 5. Follow-up and treatment provided by the same surgical team. 6. No physical or cognitive impairment that would hinder participation in the study. Exclusion Criteria 1. Diagnosis of recurrent lung cancer. 2. Previous radiotherapy treatment prior to surgery. 3. Any condition preventing walking or exercise (orthopedic, neurological, cardiovascular, metastatic, etc.). 4. Diagnosis of additional respiratory system disease such as COPD, asthma, or emphysema preventing breathing exercises. 5. Inability to complete the two-week structured exercise programme due to surgery being scheduled earlier or later than planned. 6. Complications resulting in prolonged (\>24 hours) intensive care unit stay after surgery. 7. Inability to discontinue or continue the structured exercise programme at any stage. 8. Refusal to participate in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Non-small cell lung cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hacettepe University, Ankara, Altındağ 06230
Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two-Drug combo targets stubborn KRAS lung cancer
- Smaller chest drain may speed recovery after lung cancer surgery
- Gut bacteria may hold clues to why some cancer treatments work better
- Breath-Tracking sensor aims to sharpen lung cancer scans
- Can PET scan signals predict who beats lung cancer with immunotherapy?
- Two-Drug combo takes aim at Hard-to-Treat lung cancer